SCHEMBL14021069

SCHEMBL14021069

CC(C)NC(=O)CN1CCN(C(=O)c2ccc(Nc3nccc(-c4ccc(SCCCO)cc4)n3)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 10/20 0.46
▸ HDAC1 Q13547 5/20 0.46
▸ HDAC6 Q9UBN7 4/20 0.46
▸ CDK2 P24941 2/20 0.45
▸ CDK1 P06493 1/20 0.45
▸ IKBKB O14920 3/20 0.44
▸ CHUK O15111 3/20 0.44
▸ IKBKG Q9Y6K9 3/20 0.44
▸ MYLK4 Q86YV6 2/20 0.42
▸ STK17A Q9UEE5 2/20 0.42
▸ NEK3 P51956 2/20 0.42
▸ LIMK1 P53667 1/20 0.42
▸ NEK5 Q6P3R8 1/20 0.42
▸ MTOR P42345 1/20 0.42
▸ SMG1 Q96Q15 1/20 0.42
▸ JAK3 P52333 5/20 0.41
▸ DYRK2 Q92630 1/20 0.40
▸ PLK4 O00444 2/20 0.39
▸ JAK1 P23458 2/20 0.39
▸ TYK2 P29597 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8313394 0.98 IKBKB (0.46) JAK2HDAC1HDAC6CDK2CDK1
SCHEMBL14063854 0.95 CDK2 (0.46) JAK2HDAC1HDAC6CDK2CDK1
SCHEMBL8309514 0.91 JAK2 (0.45) JAK2HDAC1HDAC6CDK2CDK1
SCHEMBL14063861 0.90 IKBKB (0.47) JAK2HDAC1HDAC6CDK2CDK1
SCHEMBL14063869 0.89 CDK1 (0.44) JAK2HDAC1HDAC6CDK2CDK1
SCHEMBL14021551 0.88 NOS3 (0.44) NOS3NOS1
SCHEMBL14021585 0.87 CDK1 (0.53) JAK2HDAC1HDAC6CDK2CDK1
SCHEMBL5070979 0.86 IKBKB (0.47) JAK2HDAC1HDAC6CDK2CDK1
SCHEMBL14021233 0.86 CDK1 (0.49) JAK2HDAC1HDAC6CDK2CDK1
SCHEMBL8313335 0.84 IKBKB (0.49) JAK2HDAC1HDAC6CDK2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
Send feedback